| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/16/2005 | WO2004071404A3 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 06/16/2005 | WO2004069159A3 Vitamin receptor binding drug delivery conjugates |
| 06/16/2005 | WO2004065936A3 Immunoglobulin e detection in mammalian species |
| 06/16/2005 | WO2004060280A3 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 06/16/2005 | WO2004056847A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 06/16/2005 | WO2004043238A8 Biomarkers for intra-amniotic inflammation |
| 06/16/2005 | WO2003033646A3 Compositions and methods for the modulation of viral maturation |
| 06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 06/16/2005 | WO1990004979A8 Method of preventing or reducing eosinophilia |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131221 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 06/16/2005 | US20050131219 Methods for reducing complexity of a sample using small epitope antibodies |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |
| 06/16/2005 | US20050130899 Tumor antigens |
| 06/16/2005 | US20050130886 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 06/16/2005 | US20050130320 Using antibody imaging to determine concentration and distribution of proteins in cells and tissues; immunoaffinity chromatography |
| 06/16/2005 | US20050130302 Method and composition for regulating expansion of stem cells |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130270 Use of nucleoside derivatives comprising a citrate group for the production of antibodies having an affinity for triphosphorylated nucleosides |
| 06/16/2005 | US20050130266 Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immounogobulins of camelidae |
| 06/16/2005 | US20050130244 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050130225 Ecstasy haptens and immunogens |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis |
| 06/16/2005 | US20050130208 Displacement assay for detection of small molecules |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130151 Fragile X mental retardation protein (FMRP) binding site for use as tool in detection, treatment and prevention of cognitive and motor disorders |
| 06/16/2005 | US20050130146 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/16/2005 | US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening |
| 06/16/2005 | US20050130130 Killer cell activatory receptor ligand for use in diagnosis, prevention and treatment of infection, cell proliferative, autoimmune and arthritic disorders |
| 06/16/2005 | US20050130128 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 06/16/2005 | US20050129717 Novel uses |
| 06/16/2005 | US20050129702 Tick chitinase |
| 06/16/2005 | US20050129701 Antibody to latent membrane proteins and uses thereof |
| 06/16/2005 | US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines |
| 06/16/2005 | US20050129699 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 06/16/2005 | US20050129697 Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides |
| 06/16/2005 | US20050129696 Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids |
| 06/16/2005 | US20050129695 At least one variable region comprising at least one heavy chain and at least one light chain of selected amino acid sequences; vectors, host cells, transgenic animals or plants, diagnosis; Alzheimer's Disease |
| 06/16/2005 | US20050129693 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| 06/16/2005 | US20050129692 Methods of expressing integrin beta6 subunits |
| 06/16/2005 | US20050129691 Using A beta antibody antagonist eg immunoglobulin; obsessive-compulsive disorder, panic disorder, panic attack, agoraphobia, post-traumatic stress disorder, social phobia, disruptive behavior disorder, and chronic fatigue syndrome |
| 06/16/2005 | US20050129690 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 06/16/2005 | US20050129689 Method for treatment of tumors using photodynamic therapy |
| 06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
| 06/16/2005 | US20050129687 Use of inhibitors of PACAP receptor activity for treatment of overactive bladder and pelvic floor pain syndrome |
| 06/16/2005 | US20050129686 Use of NOTCH pathway interfering agents for treatment of plasma cell disorders |
| 06/16/2005 | US20050129681 Inhibiting endothelial cell adhesion and migration; limit specific binding of integrin alpha 4 beta 1; antitumor |
| 06/16/2005 | US20050129680 Antimicrobial activity of antibodies |
| 06/16/2005 | US20050129678 Using computer modeling to postulate amino acid composition of protein binding sites; bioinformatic and rational drug design |
| 06/16/2005 | US20050129677 Altering the degree of internalization of the toxin; preventing or treating botulinum toxin intoxication; treating metabolic disorders, muscular disorders, nervous system disorders, and/or pain conditions |
| 06/16/2005 | US20050129670 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | US20050129616 Antibodies that immunospecifically bind to TRAIL receptors |
| 06/16/2005 | US20050129614 Cancer, immune system diseases and disorders including autoimmune disease, rheumatoid arthritis, graft rejection, graft vs. host disease, and lymphadenopathy |
| 06/16/2005 | DE10353621A1 Oligonucleotide-peptide used in nucleic acid analysis, is made by covalent bonding of defined marker-peptide chain to oligonucleotide |
| 06/16/2005 | DE10353175A1 Humaner monoklonaler Antikörper mit fettsenkender Wirkung Human monoclonal antibodies with fat-reducing |
| 06/16/2005 | DE10352900A1 Method of making pharmaceutical composition for treatment of illnesses associated with deficient costimulation ability of T-cells, employs superagonistic monoclonal antibody |
| 06/16/2005 | CA2765442A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764400A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764298A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2548942A1 Anti-sars monoclonal antibodies |
| 06/16/2005 | CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 06/16/2005 | CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 06/16/2005 | CA2547885A1 Methods for obtaining gene tags |
| 06/16/2005 | CA2547655A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2547226A1 Use of l-isoaspartyl methyltransferase as longevity marker in seeds |
| 06/16/2005 | CA2547016A1 Humanized antibodies against vascular endothelial growth factor |
| 06/16/2005 | CA2546796A1 Peptide hormones zalpha48 and zsig97 |
| 06/16/2005 | CA2546017A1 Use of notch pathway interfering agents for treatment of plasma cell disorders |
| 06/16/2005 | CA2545408A1 Selective neuropeptide y2 receptor agonists |
| 06/16/2005 | CA2528182A1 Antibodies specific for cancer associated antigen sm5-1 and uses thereof |
| 06/15/2005 | EP1542018A2 Method for detecting proteins |
| 06/15/2005 | EP1542012A1 Antibodies for detecting efavirenz |
| 06/15/2005 | EP1541689A2 Hybrid proteins which form heterodimers |
| 06/15/2005 | EP1541686A1 CONSTRUCTION OF ANTIBODY USING MRL/lPR MOUSE |
| 06/15/2005 | EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 06/15/2005 | EP1541680A1 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 06/15/2005 | EP1541677A1 Novel proteins and use thereof |
| 06/15/2005 | EP1541676A1 Antibodies to fragment F1+2 of prothrombin, their production and use |
| 06/15/2005 | EP1541588A1 Single chain antibody and utilization thereof |
| 06/15/2005 | EP1541165A1 Method of stabilizing protein solution preparation |
| 06/15/2005 | EP1540559A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/15/2005 | EP1540349A1 Process for differential diagnosis of alzheimer s dementia i n patients exhibiting mild cognitive impairment |
| 06/15/2005 | EP1540348A2 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 06/15/2005 | EP1540341A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 06/15/2005 | EP1540332A1 Methods of screening compounds for grk6 modulating activity |
| 06/15/2005 | EP1539957A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 06/15/2005 | EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/15/2005 | EP1539947A2 Humanized rabbit antibodies |
| 06/15/2005 | EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 06/15/2005 | EP1539931A1 Differentiation modulating agents and uses therefor |
| 06/15/2005 | EP1539823A1 Obtaining and use of therapeutic antibodies entering into the cell |
| 06/15/2005 | EP1539822A2 Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells |
| 06/15/2005 | EP1539821A2 Specific isotype antibodies of secretion-excretion anti-antigens of i leishmania sp /i of promastigote i /i or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effect |
| 06/15/2005 | EP1539820A2 Ostertagia vaccine |
| 06/15/2005 | EP1539819A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 06/15/2005 | EP1539818A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |